Clinical Trials for Refractory ALK Positive Large B-Cell Lymphoma

Find clinical trials for refractory alk positive large b-cell lymphoma. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

TTI-622 in Combination With Pembrolizumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma

NCT ID: NCT05507541

This clinical trial is exploring a new treatment option for patients with a type of blood cancer called diffuse large B-cell lymphoma, which has either returned after treatment or has not responded...

Recruiting

Phase: PHASE2 Type: interventional Locations: Rochester, Minnesota, United States, Iowa City, Iowa, United States +1 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions